These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18564111)

  • 1. Predictive factors for hepatocellular carcinoma in type 1 autoimmune hepatitis.
    Montano-Loza AJ; Carpenter HA; Czaja AJ
    Am J Gastroenterol; 2008 Aug; 103(8):1944-51. PubMed ID: 18564111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
    N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and patient survival in hepatocellular carcinoma: does the physician's level of experience matter?
    Chen TM; Chang TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e179-88. PubMed ID: 18466287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of alcohol, cigarette smoking, and diabetes on occurrence of hepatocellular carcinoma in patients with transfusion-acquired hepatitis C virus infection who develop cirrhosis.
    Di Costanzo GG; De Luca M; Tritto G; Lampasi F; Addario L; Lanza AG; Tartaglione MT; Picciotto FP; Ascione A
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):674-9. PubMed ID: 18679071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
    Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P
    Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favorable outcomes of autoimmune hepatitis in a community clinic setting.
    Seo S; Toutounjian R; Conrad A; Blatt L; Tong MJ
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1410-4. PubMed ID: 18373564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
    Stroffolini T; Almasio PL; Persico M; Bollani S; Benvegnù L; Di Costanzo G; Pastore G; Aghemo A; Stornaiuolo G; Mangia A; Andreone P; Stanzione M; Mazzella G; Saracco G; Del Poggio P; Bruno S;
    Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study.
    Bräu N; Fox RK; Xiao P; Marks K; Naqvi Z; Taylor LE; Trikha A; Sherman M; Sulkowski MS; Dieterich DT; Rigsby MO; Wright TL; Hernandez MD; Jain MK; Khatri GK; Sterling RK; Bonacini M; Martyn CA; Aytaman A; Llovet JM; Brown ST; Bini EJ;
    J Hepatol; 2007 Oct; 47(4):527-37. PubMed ID: 17692986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factors for early recurrence after surgical resection for hepatocellular carcinoma].
    Park UJ; Kim YH; Kang KJ; Lim TJ
    Korean J Hepatol; 2008 Sep; 14(3):371-80. PubMed ID: 18815460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for recurrence of autoimmune hepatitis after liver transplantation.
    Montano-Loza AJ; Mason AL; Ma M; Bastiampillai RJ; Bain VG; Tandon P
    Liver Transpl; 2009 Oct; 15(10):1254-61. PubMed ID: 19790153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis.
    Suzuki A; Lymp J; Donlinger J; Mendes F; Angulo P; Lindor K
    Clin Gastroenterol Hepatol; 2007 Feb; 5(2):259-64. PubMed ID: 17174610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey.
    Chalasani N; Said A; Ness R; Hoen H; Lumeng L
    Am J Gastroenterol; 1999 Aug; 94(8):2224-9. PubMed ID: 10445554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection.
    Hung IF; Poon RT; Lai CL; Fung J; Fan ST; Yuen MF
    Am J Gastroenterol; 2008 Jul; 103(7):1663-73. PubMed ID: 18616655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy.
    Verma S; Gunuwan B; Mendler M; Govindrajan S; Redeker A
    Am J Gastroenterol; 2004 Aug; 99(8):1510-6. PubMed ID: 15307869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of survival after resection of early hepatocellular carcinoma.
    Nathan H; Schulick RD; Choti MA; Pawlik TM
    Ann Surg; 2009 May; 249(5):799-805. PubMed ID: 19387322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A predictive model for the development of hepatocellular carcinoma, liver failure, or liver transplantation for patients presenting to clinic with chronic hepatitis C.
    Bonis PA; Tong MJ; Blatt LM; Conrad A; Griffith JL
    Am J Gastroenterol; 1999 Jun; 94(6):1605-12. PubMed ID: 10364032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India.
    Paul SB; Chalamalasetty SB; Vishnubhatla S; Madan K; Gamanagatti SR; Batra Y; Gupta SD; Panda SK; Acharya SK
    Oncology; 2009; 77(3-4):162-71. PubMed ID: 19641335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B.
    Yuen MF; Tanaka Y; Fong DY; Fung J; Wong DK; Yuen JC; But DY; Chan AO; Wong BC; Mizokami M; Lai CL
    J Hepatol; 2009 Jan; 50(1):80-8. PubMed ID: 18977053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with cirrhosis and bare-stent TIPS may have increased risk of hepatocellular carcinoma.
    Bañares R; Núñez O; Escudero M; Fernández C; Vaquero J; Beceiro I; Echenagusía A; Clemente G; Santos L
    Hepatology; 2005 Mar; 41(3):566-71. PubMed ID: 15726654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.